Clincosm LogoSign in Get a demo

Advanced Hepatocellular Carcinoma

Showing 51 - 75 of 86
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Hepatocellular Carcinoma, Liver Cancer, Hepatic Cancer Trial in Worldwide (CS-1008 2 mg/kg, Sorafenib, CS-1008 6/2

Completed
Has Results
  • Advanced Hepatocellular Carcinoma
  • +3 more
  • CS-1008 2 mg/kg
  • +5 more
  • Los Angeles, California
  • +27 more
Apr 6, 2021

Radiotherapy, Toripalimab, Sorafenib Trial in Beijing (Radiotherapy plus Toripalimab, Sorafenib)

Recruiting
  • Radiotherapy
  • +3 more
  • Beijing, Beijing, China
    Bo Chen
Mar 6, 2021

Advanced Hepatocellular Carcinoma Trial in Shanghai (Oligo Fucoidan, Placebo)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Oligo Fucoidan
  • Placebo
  • Shanghai, China
    Fudan University Zhongshan Hospital
Feb 8, 2021

Advanced Hepatocellular Carcinoma Trial in Beijing (Sintilimab+IBI305)

Completed
  • Advanced Hepatocellular Carcinoma
  • Beijing, China
    National Cancer Center/Cancer Hospital, Chinese ACademy of Medic
Jan 29, 2021

ATEZOLIZUMAB - BEVACIZUMAB in Treatment Hepatocellular Carcinoma

Unknown status
  • Advanced Hepatocellular Carcinoma
    • (no location specified)
    Jan 26, 2021

    Advanced Hepatocellular Carcinoma Trial in Taipei (Tislelizumab+regorafenib for part 1;Tislelizumab+regorafenib for group 1 of

    Recruiting
    • Advanced Hepatocellular Carcinoma
    • Tislelizumab+regorafenib for part 1;Tislelizumab+regorafenib for group 1 of part 2; Regorafenib for group 2 of part 2.
    • Taipei, Zhongzheng Dist, Taiwan
      National Taiwan University Hospital
    Dec 21, 2020

    Advanced Hepatocellular Carcinoma Trial in Seoul (Nivolumab)

    Enrolling by invitation
    • Advanced Hepatocellular Carcinoma
    • Seoul, Korea, Republic of
      National Cancer Center, Korea
    Oct 26, 2020

    Advanced Hepatocellular Carcinoma Trial in Shanghai (IBI308 200mg)

    Recruiting
    • Advanced Hepatocellular Carcinoma
    • IBI308 200mg
    • Shanghai, China
      Zhongshan Hospital Affiliated to Fudan University
    Jun 22, 2020

    To Explore Diversity of Intestinal Flora in Advanced HCC Combin

    Not yet recruiting
    • Advanced Hepatocellular Carcinoma
      • (no location specified)
      Sep 22, 2019

      Advanced Hepatocellular Carcinoma Trial in Guangzhou (TACE, Lenvatinib)

      Recruiting
      • Advanced Hepatocellular Carcinoma
      • Guangzhou, Guangdong, China
        The First Affiliated Hospital of Sun Yat-sen University
      Aug 19, 2019

      Advanced Hepatocellular Carcinoma Trial in Nanjing (Anlotinib and Sintilimab injection)

      Unknown status
      • Advanced Hepatocellular Carcinoma
      • Anlotinib and Sintilimab injection
      • Nanjing, Jiangsu, China
        Jiangsu Province Hospital
      Aug 8, 2019

      Advanced Hepatocellular Carcinoma Trial in Incheon, Seoul (Immuncell-LC)

      Completed
      • Advanced Hepatocellular Carcinoma
      • Incheon, Korea, Republic of
      • +3 more
      Sep 25, 2017

      Advanced Hepatocellular Carcinoma Trial in Seoul & Gyeonggi-Do (OPB-111077)

      Terminated
      • Advanced Hepatocellular Carcinoma
      • Seoul & Gyeonggi-Do, Korea, Republic of
        (unnamed)
      May 7, 2017

      Advanced Hepatocellular Carcinoma Trial in United States (Oprozomib, Sorafenib)

      Withdrawn
      • Advanced Hepatocellular Carcinoma
      • Burlington, California
      • +5 more
      Apr 28, 2017

      Advanced Hepatocellular Carcinoma Trial in Kashiwa-city (ARQ 197)

      Completed
      • Advanced Hepatocellular Carcinoma
      • ARQ 197
      • Kashiwa-city, Chiba, Japan
        (unnamed)
      Feb 28, 2017

      Advanced Hepatocellular Carcinoma Trial in Worldwide (INC280, Placebo)

      Withdrawn
      • Advanced Hepatocellular Carcinoma
      • Boston, Massachusetts
      • +14 more
      Aug 30, 2016

      Advanced Hepatocellular Carcinoma Trial (Octreotide)

      Completed
      • Advanced Hepatocellular Carcinoma
      • (no location specified)
      Apr 11, 2016

      Advanced Hepatocellular Carcinoma, Inoperable Hepatocellular Carcinoma Trial (AMG 386, Sorafenib)

      Completed
      • Advanced Hepatocellular Carcinoma
      • Inoperable Hepatocellular Carcinoma
      • (no location specified)
      Mar 7, 2016

      Internal Radiation, Advanced Hepatocellular Carcinoma Trial in Shanghai (131I-chTNT-1/B)

      Completed
      • Internal Radiation
      • Advanced Hepatocellular Carcinoma
      • 131I-chTNT-1/B
      • Shanghai, Shanghai, China
        Eastern hepatobilliary surgery hospital
      Mar 28, 2016

      Advanced Hepatocellular Carcinoma Trial in Shanghai (TACE+Sorafenib, TACE)

      Unknown status
      • Advanced Hepatocellular Carcinoma
      • TACE+Sorafenib
      • TACE
      • Shanghai, Shanghai, China
        Eastern Hepatobiliary Surgery Hospital
      Mar 28, 2016

      Recurrence Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma Trial in Shanghai (procedure, biological, drug)

      Unknown status
      • Recurrence Hepatocellular Carcinoma
      • Advanced Hepatocellular Carcinoma
      • TACE
      • +5 more
      • Shanghai, China
        Eastern Hepatobiliary Surgery Hospital
      Dec 30, 2015

      Advanced Hepatocellular Carcinoma Trial in Shanghai (PIK-PD-1 cells, DC-PMAT)

      Unknown status
      • Advanced Hepatocellular Carcinoma
      • PIK-PD-1 cells
      • DC-PMAT
      • Shanghai, China
        Eastern Hepatobiliary Surgery Hospital
      Dec 30, 2015

      Advanced Hepatocellular Carcinoma Trial in Cairo, Monofeiya (Sorafenib, sorafenib plus tegafur-uracil)

      Terminated
      • Advanced Hepatocellular Carcinoma
      • Cairo, Egypt
      • +4 more
      Aug 3, 2015

      Advanced Hepatocellular Carcinoma Trial in Nanjin, (Apatinib)

      Completed
      • Advanced Hepatocellular Carcinoma
      • Nanjin,, Jiangsu, China
        Nanjin Military Eighty -one Hosiptal
      Apr 2, 2015

      Advanced Hepatocellular Carcinoma Trial in New York (Silybin)

      Completed
      • Advanced Hepatocellular Carcinoma
      • New York, New York
        Columbia University Medical Center
      Nov 21, 2013